» Articles » PMID: 29705292

EphA2 Transmembrane Domain Is Uniquely Required for Keratinocyte Migration by Regulating Ephrin-A1 Levels

Overview
Publisher Elsevier
Specialty Dermatology
Date 2018 Apr 30
PMID 29705292
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

EphA2 receptor tyrosine kinase is activated by ephrin-A1 ligand, which harbors a glycosylphosphatidylinositol anchor that enhances lipid raft localization. Although EphA2 and ephrin-A1 modulate keratinocyte migration and differentiation, the ability of this cell-cell communication complex to localize to different membrane regions in keratinocytes remains unknown. Using a combination of biochemical and imaging approaches, we provide evidence that ephrin-A1 and a ligand-activated form of EphA2 partition outside of lipid raft domains in response to calcium-mediated cell-cell contact stabilization in normal human epidermal keratinocytes. EphA2 transmembrane domain swapping with a shorter and molecularly distinct transmembrane domain of EphA1 resulted in decreased localization of this receptor tyrosine kinase at cell-cell junctions and increased expression of ephrin-A1, which is a negative regulator of keratinocyte migration. Accordingly, altered EphA2 membrane distribution at cell-cell contacts limited the ability of keratinocytes to seal linear scratch wounds in vitro in an ephrin-A1-dependent manner. Collectively, these studies highlight a key role for the EphA2 transmembrane domain in receptor-ligand membrane distribution at cell-cell contacts that modulates ephrin-A1 levels to allow for efficient keratinocyte migration with relevance for cutaneous wound healing.

Citing Articles

Cholesterol inhibits assembly and oncogenic activation of the EphA2 receptor.

Schuck R, Ward A, Sahoo A, Rybak J, Pyron R, Trybala T Commun Biol. 2025; 8(1):411.

PMID: 40069393 PMC: 11897322. DOI: 10.1038/s42003-025-07786-6.


Cholesterol inhibits assembly and activation of the EphA2 receptor.

Schuck R, Ward A, Sahoo A, Rybak J, Pyron R, Trybala T bioRxiv. 2024; .

PMID: 38915729 PMC: 11195142. DOI: 10.1101/2024.06.10.598255.


Transmembrane helix interactions regulate oligomerization of the receptor tyrosine kinase EphA2.

Wirth D, Ozdemir E, Wimley W, Pasquale E, Hristova K J Biol Chem. 2024; 300(7):107441.

PMID: 38838777 PMC: 11263659. DOI: 10.1016/j.jbc.2024.107441.


Receptor Tyrosine Kinase EPHA2 Drives Epidermal Differentiation through Regulation of EGFR Signaling.

Perez White B, Cable C, Shi B, Ventrella R, Kaplan N, Kobeissi A J Invest Dermatol. 2024; 144(8):1798-1807.e1.

PMID: 38520417 PMC: 11260533. DOI: 10.1016/j.jid.2024.01.014.


Direct quantification of ligand-induced lipid and protein microdomains with distinctive signaling properties.

Wirth D, Paul M, Pasquale E, Hristova K ChemSystemsChem. 2022; 4(5).

PMID: 36337751 PMC: 9634703. DOI: 10.1002/syst.202200011.


References
1.
Jans R, Atanasova G, Jadot M, Poumay Y . Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38. J Invest Dermatol. 2004; 123(3):564-73. DOI: 10.1111/j.0022-202X.2004.23221.x. View

2.
McGuinn K, Mahoney M . Lipid rafts and detergent-resistant membranes in epithelial keratinocytes. Methods Mol Biol. 2014; 1195:133-44. PMC: 6611731. DOI: 10.1007/7651_2014_71. View

3.
Rajendran L, Simons K . Lipid rafts and membrane dynamics. J Cell Sci. 2005; 118(Pt 6):1099-102. DOI: 10.1242/jcs.01681. View

4.
Kaplan N, Ventrella R, Peng H, Pal-Ghosh S, Arvanitis C, Rappoport J . EphA2/Ephrin-A1 Mediate Corneal Epithelial Cell Compartmentalization via ADAM10 Regulation of EGFR Signaling. Invest Ophthalmol Vis Sci. 2018; 59(1):393-406. PMC: 5774870. DOI: 10.1167/iovs.17-22941. View

5.
Barquilla A, Pasquale E . Eph receptors and ephrins: therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2014; 55:465-87. PMC: 4388660. DOI: 10.1146/annurev-pharmtox-011112-140226. View